PAR management would have a very good idea of the likely outcome by now, based purely on the information that FDA have been requesting.
The very highly paid consultants that PAR are paying, would also have a good knowledge of the likely outcome by now.
Based on the very low share trading volume and lack of share price movement, the likely FDA announcement doesn't appear to be very close, or it is going to be very uninspiring news. Either way, PAR have now got 2 months to announce their future sources of funding.
PAR. SP, page-1126
-
- There are more pages in this discussion • 127 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.015(6.98%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 20.0¢ | $201.6K | 994.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 429247 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 13806 | 2 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |